| l-2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer EH Shim, CB Livi, D Rakheja, J Tan, D Benson, V Parekh, EY Kho, ... Cancer discovery 4 (11), 1290-1298, 2014 | 268 | 2014 |
| Biochemical and epigenetic insights into L-2-hydroxyglutarate, a potential therapeutic target in renal cancer S Shelar, EH Shim, GJ Brinkley, A Kundu, F Carobbio, T Poston, J Tan, ... Clinical Cancer Research 24 (24), 6433-6446, 2018 | 65 | 2018 |
| Cyanobacterial metabolite calothrixins: recent advances in synthesis and biological evaluation S Xu, B Nijampatnam, S Dutta, SE Velu Marine Drugs 14 (1), 17, 2016 | 47 | 2016 |
| Discovery and evaluation of nNav1. 5 sodium channel blockers with potent cell invasion inhibitory activity in breast cancer cells S Dutta, OL Charcas, S Tanner, F Gradek, V Driffort, S Roger, K Selander, ... Bioorganic & medicinal chemistry 26 (9), 2428-2436, 2018 | 36 | 2018 |
| Mini-review: bmx kinase inhibitors for cancer therapy JS Jarboe, S Dutta, SE Velu, CD Willey Recent patents on anti-cancer drug discovery 8 (3), 228-238, 2013 | 36 | 2013 |
| L-2-Hydroxyglutarate: An epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov. 2014; 4: 1290–1298. doi: 10.1158/2159-8290 EH Shim, CB Livi, D Rakheja, J Tan, D Benson, V Parekh, EY Kho, ... CD-13-0696.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 24 | |
| Recent advances in isolation, synthesis, and evaluation of bioactivities of bispyrroloquinone alkaloids of marine origin B Nijampatnam, S Dutta Chinese journal of natural medicines 13 (8), 561-577, 2015 | 15 | 2015 |
| Voltage-Gated Sodium Channel NaV1.5 Controls NHE−1−Dependent Invasive Properties in Colon Cancer Cells O Lopez-Charcas, L Poisson, O Benouna, R Lemoine, S Chadet, ... Cancers 15 (1), 46, 2022 | 9 | 2022 |
| L-2-hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov 4: 1290–1298 EH Shim, CB Livi, D Rakheja, J Tan, D Benson, V Parekh, EY Kho, ... | 6 | 2014 |
| Synthesis of pyrroloquinones via a can mediated oxidative free radical reaction of 1, 3-Dicarbonyl compounds with aminoquinones T Nguyen, D Nadkarni, S Dutta, S Xu, S Kim, S Murugesan, S Velu Journal of chemistry 2013, 2013 | 6 | 2013 |
| Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl) thiazol-2-amine (SRI-22819) as NF-ҡB activators for the treatment of ALS B Mathew, P Ruiz, S Dutta, JT Entrekin, S Zhang, KD Patel, MS Simmons, ... European Journal of Medicinal Chemistry 210, 112952, 2021 | 3 | 2021 |
| Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus SK Ahmed, S Dutta, JP Tillotson, CE Augelli-Szafran, AK Pathak, ... US Patent 11,905,306, 2024 | | 2024 |
| L-2HG/L2HGDH axis as therapeutic target for kidney cancer SB Shelar, E Shim, G Brinkley, A Kundu, H Nam, F Carobbio, T Poston, ... Cancer Research 78 (13_Supplement), 5482-5482, 2018 | | 2018 |
| Targeting Voltage Gated Sodium Channels for Prevention of Breast Cancer Metastasis S Dutta | | 2016 |
| Voltage gated sodium channels: A novel target for breast cancer metastasis therapy S Dutta, S Roger, S Velu, W Brouillette ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 245, 2013 | | 2013 |
